Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Gynecologic 1Dermatologic 1

Conditions

Melanoma 791Carcinoma, Non-Small-Cell Lung 171Skin Neoplasms 154Neoplasms 107Neoplasm Metastasis 100Colorectal Neoplasms 96Carcinoma, Renal Cell 96Uveal Melanoma 92Breast Neoplasms 88Squamous Cell Carcinoma of Head and Neck 85Carcinoma, Basal Cell 85Lung Neoplasms 80Ovarian Neoplasms 79Lymphoma, T-Cell, Cutaneous 67Carcinoma, Merkel Cell 67Sarcoma 66Pancreatic Neoplasms 59Stomach Neoplasms 58Head and Neck Neoplasms 55Carcinoma, Hepatocellular 54Uterine Cervical Neoplasms 53Urinary Bladder Neoplasms 50Triple Negative Breast Neoplasms 44Esophageal Neoplasms 44Prostatic Neoplasms 43Endometrial Neoplasms 42Carcinoma, Squamous Cell 39Brain Neoplasms 39Carcinoma, Transitional Cell 37Lymphoma 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ataxia Telangiectasia × Dermatologic × 1 year × Clear all
NCT07371663 2026-01-28

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

Beijing Tide Pharmaceutical Co., Ltd

Phase 1/2 Recruiting
266 enrolled
DermatologicGastrointestinalGynecologicThoracic

Ataxia Telangiectasia, Carcinoma, Non-Small-Cell Lung, Melanoma, Stomach Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡